Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

11
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
11
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

17
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
17

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IV bolus, maintenance and medication carrier fluid in children with community-acquired sepsis: a multicentre cohort study.

Archives of disease in childhood·2026
Same author

Hypothermia and Mortality Among Children in the Emergency Department.

Pediatrics·2026
Same author

Balanced Fluid or 0.9% Saline in Children Treated for Septic Shock.

The New England journal of medicine·2026
Same author

Executive Summary: Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·2026
Same author

Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·2026
Same author

Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026.

Intensive care medicine·2026

Related Experiment Video

Updated: Oct 5, 2025

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
08:44

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

2.6K

Multisystem Inflammatory Syndrome in Children: Examining Emerging Data and Identifying Key Knowledge Gaps.

Laura F Sartori1, Fran Balamuth

  • 1From the Assistant Professor and Associate Professor of Pediatrics, Perelman School of Medicine at the University of Pennsylvania; and Division of Pediatric Emergency Medicine and Pediatric Sepsis Program, Children's Hospital of Philadelphia, Philadelphia, PA.

Pediatric Emergency Care
|February 1, 2022
PubMed
Summary

Multisystem inflammatory syndrome in children (MIS-C) is a rare immune response to COVID-19, affecting children and causing organ damage. MIS-C has distinct features from Kawasaki disease, but treatment guidelines are still developing.

More Related Videos

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

10.6K
A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
07:01

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

586

Related Experiment Videos

Last Updated: Oct 5, 2025

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
08:44

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

2.6K
Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

10.6K
A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
07:01

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

586

Area of Science:

  • Pediatric infectious diseases
  • Immunology
  • Cardiovascular medicine

Background:

  • Multisystem inflammatory syndrome in children (MIS-C) is a serious condition following SARS-CoV-2 infection.
  • MIS-C can lead to significant organ dysfunction, particularly severe cardiovascular compromise in children.
  • Evidence suggests MIS-C differs clinically and in laboratory findings from Kawasaki disease.

Purpose of the Study:

  • To delineate the distinct clinical and laboratory features of MIS-C compared to Kawasaki disease.
  • To highlight the need for evidence-based treatment strategies and long-term outcome data for MIS-C.

Main Methods:

  • Comparative analysis of clinical presentations and laboratory results in children with MIS-C and Kawasaki disease.
  • Review of existing literature on MIS-C pathophysiology and clinical manifestations.

Main Results:

  • MIS-C typically affects older children than Kawasaki disease.
  • MIS-C is associated with more pronounced gastrointestinal and neurological symptoms.
  • Laboratory findings in MIS-C often show increased inflammation, lymphopenia, and cardiac injury.

Conclusions:

  • MIS-C presents a distinct profile compared to Kawasaki disease, necessitating specific diagnostic and management approaches.
  • Further research is crucial to establish best practices for MIS-C treatment and understand its long-term consequences.